Structure-Based Design of Hepatitis C Virus E2 Glycoprotein Improves Serum Binding and Cross-Neutralization

An effective vaccine for hepatitis C virus (HCV) is a major unmet need, and it requires an antigen that elicits immune responses to key conserved epitopes. Based on structures of antibodies targeting HCV envelope glycoprotein E2, we designed immunogens to modulate the structure and dynamics of E2 an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Virol
Main Authors: Pierce, Brian G., Keck, Zhen-Yong, Wang, Ruixue, Lau, Patrick, Garagusi, Kyle, Elkholy, Khadija, Toth, Eric A., Urbanowicz, Richard A., Guest, Johnathan D., Agnihotri, Pragati, Kerzic, Melissa C., Marin, Alexander, Andrianov, Alexander K., Ball, Jonathan K., Mariuzza, Roy A., Fuerst, Thomas R., Foung, Steven K. H.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2020
Assuntos:
Vaccines and Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7592221/
https://ncbi.nlm.nih.gov/pubmed/32878891
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.00704-20
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados